USA
Acceder
Cotización de Corcept Therapeutics Incorporated (CORT) hoy en tiempo real
Análisis técnico y gráfico histórico de Corcept Therapeutics Incorporated
Análisis fundamental y estadísticas clave de Corcept Therapeutics Incorporated
Ficha de Corcept Therapeutics Incorporated (CORT)
| Ticker | CORT |
|---|---|
| ISIN | US2183521028 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Análisis financiero de Corcept Therapeutics Incorporated
Resumen financiero e información corporativa de Corcept Therapeutics Incorporated
Ratios de valoración: PER, EV/EBITDA y métricas de Corcept Therapeutics Incorporated
Márgenes de rentabilidad y Cash Flow de Corcept Therapeutics Incorporated
BPA, Dividendos y Valor Contable: Métricas por acción de Corcept Therapeutics Incorporated
Solvencia y deuda: Análisis del balance de Corcept Therapeutics Incorporated
Ratios de liquidez y Test Ácido: Capacidad de pago de Corcept Therapeutics Incorporated
Invertir en Corcept Therapeutics Incorporated en 2026: Preguntas frecuentes
¿Qué es Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surger...
¿En qué sector opera Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated opera en el sector Healthcare, industria Biotechnology.
Otras acciones del sector Atención sanitaria